BILIARY ATRESIA
Clinical trials for BILIARY ATRESIA explained in plain language.
Never miss a new study
Get alerted when new BILIARY ATRESIA trials appear
Sign up with your email to follow new studies for BILIARY ATRESIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for kids with rare liver disease: 2-Year drug trial aims to prevent transplants
Disease control ENROLLING_BY_INVITATIONThis study is a 2-year follow-up to see if a drug called odevixibat can help children with biliary atresia live longer without needing a liver transplant. It will track about 180 children who were in a previous study to measure the drug's long-term safety and its effect on liver …
Matched conditions: BILIARY ATRESIA
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Race against time: can new drug save Kids' livers?
Disease control OngoingThis study is testing whether a medicine called odevixibat can help children with biliary atresia who have had Kasai surgery. The main goal is to see if the drug can delay or prevent the need for a liver transplant and reduce harmful bile acids in the blood. About 254 children wi…
Matched conditions: BILIARY ATRESIA
Phase: PHASE3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC